Pediatrix Medical Group (NYSE:MD) Trading Down 4.1%

Pediatrix Medical Group, Inc. (NYSE:MD)’s share price dropped 4.1% during mid-day trading on Monday . The stock traded as low as $10.08 and last traded at $10.11. Approximately 16,298 shares traded hands during trading, a decline of 98% from the average daily volume of 918,991 shares. The stock had previously closed at $10.54.

Analyst Ratings Changes

Several equities research analysts recently weighed in on MD shares. UBS Group boosted their price target on shares of Pediatrix Medical Group from $9.00 to $10.50 and gave the stock a “neutral” rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 price target on the stock in a research report on Friday, June 7th. StockNews.com upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Finally, Truist Financial boosted their target price on shares of Pediatrix Medical Group from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Six analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus price target of $9.30.

Pediatrix Medical Group Trading Up 0.9 %

The company’s fifty day moving average price is $8.97 and its 200-day moving average price is $8.69. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.38 and a quick ratio of 1.38. The stock has a market cap of $913.66 million, a price-to-earnings ratio of -12.49, a P/E/G ratio of 1.65 and a beta of 1.56.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.31 by $0.03. Pediatrix Medical Group had a positive return on equity of 10.59% and a negative net margin of 12.58%. The business had revenue of $504.30 million for the quarter, compared to analyst estimates of $505.49 million. During the same quarter in the prior year, the firm posted $0.37 EPS. The business’s quarterly revenue was up .7% compared to the same quarter last year. On average, research analysts expect that Pediatrix Medical Group, Inc. will post 1.18 EPS for the current fiscal year.

Insider Activity

In other news, CFO C Marc Richards sold 17,438 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $10.08, for a total transaction of $175,775.04. Following the transaction, the chief financial officer now owns 175,347 shares in the company, valued at approximately $1,767,497.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Pediatrix Medical Group news, CFO C Marc Richards sold 17,438 shares of the firm’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $10.08, for a total value of $175,775.04. Following the completion of the sale, the chief financial officer now directly owns 175,347 shares of the company’s stock, valued at approximately $1,767,497.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Laura A. Linynsky sold 7,000 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $11.16, for a total value of $78,120.00. Following the sale, the director now directly owns 30,805 shares of the company’s stock, valued at $343,783.80. The disclosure for this sale can be found here. Insiders have sold 68,100 shares of company stock worth $701,889 in the last quarter. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently bought and sold shares of MD. Victory Capital Management Inc. raised its holdings in shares of Pediatrix Medical Group by 191.9% in the fourth quarter. Victory Capital Management Inc. now owns 118,131 shares of the company’s stock valued at $1,099,000 after buying an additional 77,658 shares during the last quarter. M&T Bank Corp increased its position in Pediatrix Medical Group by 6.9% during the 4th quarter. M&T Bank Corp now owns 48,771 shares of the company’s stock worth $453,000 after purchasing an additional 3,157 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in Pediatrix Medical Group by 10.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after acquiring an additional 148,600 shares during the period. Jump Financial LLC purchased a new position in Pediatrix Medical Group in the fourth quarter worth $154,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Pediatrix Medical Group by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,409,884 shares of the company’s stock valued at $41,013,000 after purchasing an additional 59,336 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.